Intervet Inc. (doing business as Merck Animal Health) is voluntarily recalling 23,986 vials of Banamine (flunixin meglumine injection) and Banamine-S (flunixin meglumine injection) due to the presence of particulate matter. The recall affects 100 mL and 250 mL vials of these veterinary injectable medications used to treat inflammation and fever in horses, cattle, and swine. The particulates were identified during routine quality testing of the affected lots.
Injecting a product containing particulate matter can cause local irritation, inflammation, or more serious systemic issues such as blockages in blood vessels or allergic reactions in animals. No adverse events or injuries have been reported to date in connection with this recall.
You have 2 options:
Approved by FDA under NADA # 101-479; Formulated in Germany by Vet Pharma Friesoythe GmbH.
Approved by FDA under NADA # 101-479; Formulated in Germany by Vet Pharma Friesoythe GmbH.
Approved by FDA under NADA # 101-479; Formulated in Germany by Vet Pharma Friesoythe GmbH.
Image 1 “Photograph of front and side labeling, Banamine 250 mL”
Image 2 “Photograph of front and side labeling, Banamine 100 mL”
Image 3 “Photograph of front and side labeling, Banamine-S 100 mL”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response